Global Radiopharmaceuticals Market Analysis 2017 - Forecast to 2022

  • ID: 4301755
  • Report
  • Region: Global
  • 171 pages
  • Hoovers Research
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Bracco Imaging SpA
  • Covidien Plc
  • Daiichi Sankyo Co., Ltd.
  • Eckert & Ziegler
  • Guerbet Group
  • MORE
The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Radiopharmaceuticals". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2014 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:
  • Market Sizing estimations and forecasts for 6 years across the given market segments
  • Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities,)
  • Strategic recommendations in key business segments based on the market estimations
  • Regional and country level market analysis
  • Competitive landscaping of major market players
  • Company profiling covering the financials, recent activities and the future strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Bracco Imaging SpA
  • Covidien Plc
  • Daiichi Sankyo Co., Ltd.
  • Eckert & Ziegler
  • Guerbet Group
  • MORE
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Radiopharmaceuticals Market by Modality
5.1 Introduction
5.2 Beta Emitters
5.2.1 Strontium 89
5.2.2 Yttrium 90
5.2.3 Samarium 153
5.2.4 Rhenium 186/188
5.2.5 Phosphorus 32
5.2.6 Iodine 131
5.2.7 Other Beta Emitters
5.3 Alpha Emitters
5.3.1 Radium 223
5.3.2 Bismuth 213
5.3.3 Other Alpha Emitters
5.4 Brachytherapy Isotopes
5.4.1 Palladium 103
5.4.2 Iodine 125
5.4.3 Cesium 131
5.4.4 Other Brachytherapy Isotopes
5.5 PET Radiopharmaceuticals
5.5.1 Rubidium 82
5.5.2 Fluorine 18
5.5.3 Other PET Radiopharmaceuticals
5.6 SPECT Radiopharmaceuticals
5.6.1 Fluorine 18
5.6.2 Iodine 123
5.6.3 Technetium 99m
5.6.4 Thallium 201
5.6.5 Xenon 133
5.6.6 Other SPECT Radiopharmaceuticals

6 Radiopharmaceuticals Market by Application
6.1 Introduction
6.2 Cardiology
6.3 Bone Metastasis
6.4 Endocrine Tumors
6.5 Lymphoma
6.6 Thyroid
6.7 Neurology
6.8 Oncology
6.9 Gastroenterology
6.10 Other Applications

7 Radiopharmaceuticals Market by End User
7.1 Introduction
7.2 Diagnostic Imaging Centers
7.3 Ambulatory Surgical Centers
7.4 Cancer research Institutes
7.5 Hospitals

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 RoW
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Siemens Healthineers (Siemens AG)
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Advanced Accelerator Applications
10.3 Bayer AG
10.4 Bracco Imaging SpA
10.5 Covidien Plc
10.6 Daiichi Sankyo Co., Ltd.
10.7 Eckert & Ziegler
10.8 GE Healthcare (General Electric Co.)
10.9 Guerbet Group
10.10 IBA Molecular Imaging
10.11 Lantheus Medical Imaging, Inc
10.12 Mallinckrodt plc
10.13 Nordion, Inc.
10.14 Positron Corporation
10.15 NTP Radioisotopes Pty Ltd
10.16 Advanced Medical Isotope Corp
10.17 Fujifilm RI Pharma Co. Ltd
10.18 Eczacibasi-Monrol Nuclear Products

11 Appendix

12 Disclaimer

List of Tables
Table 1 Global Radiopharmaceuticals Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Radiopharmaceuticals Market Analysis, by Modality, 2013-2022 ($MN)
Table 3 Global Radiopharmaceuticals Market Analysis, by Beta Emitters, 2013-2022 ($MN)
Table 4 Global Radiopharmaceuticals Market Analysis, by Strontium 89, 2013-2022 ($MN)
Table 5 Global Radiopharmaceuticals Market Analysis, by Yttrium 90, 2013-2022 ($MN)
Table 6 Global Radiopharmaceuticals Market Analysis, by Samarium 153, 2013-2022 ($MN)
Table 7 Global Radiopharmaceuticals Market Analysis, by Rhenium 186/188, 2013-2022 ($MN)
Table 8 Global Radiopharmaceuticals Market Analysis, by Phosphorus 32, 2013-2022 ($MN)
Table 9 Global Radiopharmaceuticals Market Analysis, by Iodine 131, 2013-2022 ($MN)
Table 10 Global Radiopharmaceuticals Market Analysis, by Other Beta Emitters, 2013-2022 ($MN)
Table 11 Global Radiopharmaceuticals Market Analysis, by Alpha Emitters, 2013-2022 ($MN)
Table 12 Global Radiopharmaceuticals Market Analysis, by Radium 223, 2013-2022 ($MN)
Table 13 Global Radiopharmaceuticals Market Analysis, by Bismuth 213, 2013-2022 ($MN)
Table 14 Global Radiopharmaceuticals Market Analysis, by Other Alpha Emitters, 2013-2022 ($MN)
Table 15 Global Radiopharmaceuticals Market Analysis, by Brachytherapy Isotopes, 2013-2022 ($MN)
Table 16 Global Radiopharmaceuticals Market Analysis, by Palladium 103, 2013-2022 ($MN)
Table 17 Global Radiopharmaceuticals Market Analysis, by Iodine 125, 2013-2022 ($MN)
Table 18 Global Radiopharmaceuticals Market Analysis, by Cesium 131, 2013-2022 ($MN)
Table 19 Global Radiopharmaceuticals Market Analysis, by Other Brachytherapy Isotopes, 2013-2022 ($MN)
Table 20 Global Radiopharmaceuticals Market Analysis, by PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 21 Global Radiopharmaceuticals Market Analysis, by Rubidium 82, 2013-2022 ($MN)
Table 22 Global Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 23 Global Radiopharmaceuticals Market Analysis, by Other PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 24 Global Radiopharmaceuticals Market Analysis, by SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 25 Global Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 26 Global Radiopharmaceuticals Market Analysis, by Iodine 123, 2013-2022 ($MN)
Table 27 Global Radiopharmaceuticals Market Analysis, by Technetium 99m, 2013-2022 ($MN)
Table 28 Global Radiopharmaceuticals Market Analysis, by Thallium 201, 2013-2022 ($MN)
Table 29 Global Radiopharmaceuticals Market Analysis, by Xenon 133, 2013-2022 ($MN)
Table 30 Global Radiopharmaceuticals Market Analysis, by Other SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 31 Global Radiopharmaceuticals Market Analysis, by Application, 2013-2022 ($MN)
Table 32 Global Radiopharmaceuticals Market Analysis, by Cardiology, 2013-2022 ($MN)
Table 33 Global Radiopharmaceuticals Market Analysis, by Bone Metastasis, 2013-2022 ($MN)
Table 34 Global Radiopharmaceuticals Market Analysis, by Endocrine Tumors, 2013-2022 ($MN)
Table 35 Global Radiopharmaceuticals Market Analysis, by Lymphoma, 2013-2022 ($MN)
Table 36 Global Radiopharmaceuticals Market Analysis, by Thyroid, 2013-2022 ($MN)
Table 37 Global Radiopharmaceuticals Market Analysis, by Neurology, 2013-2022 ($MN)
Table 38 Global Radiopharmaceuticals Market Analysis, by Oncology, 2013-2022 ($MN)
Table 39 Global Radiopharmaceuticals Market Analysis, by Gastroenterology, 2013-2022 ($MN)
Table 40 Global Radiopharmaceuticals Market Analysis, by Other Applications, 2013-2022 ($MN)
Table 41 Global Radiopharmaceuticals Market Analysis, by End User, 2013-2022 ($MN)
Table 42 Global Radiopharmaceuticals Market Analysis, by Diagnostic Imaging Centers, 2013-2022 ($MN)
Table 43 Global Radiopharmaceuticals Market Analysis, by Ambulatory Surgical Centers, 2013-2022 ($MN)
Table 44 Global Radiopharmaceuticals Market Analysis, by Cancer research Institutes, 2013-2022 ($MN)
Table 45 Global Radiopharmaceuticals Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 46 North America Radiopharmaceuticals Market Analysis, by Country, 2013-2022 ($MN)
Table 47 North America Radiopharmaceuticals Market Analysis, by Modality, 2013-2022 ($MN)
Table 48 North America Radiopharmaceuticals Market Analysis, by Beta Emitters, 2013-2022 ($MN)
Table 49 North America Radiopharmaceuticals Market Analysis, by Strontium 89, 2013-2022 ($MN)
Table 50 North America Radiopharmaceuticals Market Analysis, by Yttrium 90, 2013-2022 ($MN)
Table 51 North America Radiopharmaceuticals Market Analysis, by Samarium 153, 2013-2022 ($MN)
Table 52 North America Radiopharmaceuticals Market Analysis, by Rhenium 186/188, 2013-2022 ($MN)
Table 53 North America Radiopharmaceuticals Market Analysis, by Phosphorus 32, 2013-2022 ($MN)
Table 54 North America Radiopharmaceuticals Market Analysis, by Iodine 131, 2013-2022 ($MN)
Table 55 North America Radiopharmaceuticals Market Analysis, by Other Beta Emitters, 2013-2022 ($MN)
Table 56 North America Radiopharmaceuticals Market Analysis, by Alpha Emitters, 2013-2022 ($MN)
Table 57 North America Radiopharmaceuticals Market Analysis, by Radium 223, 2013-2022 ($MN)
Table 58 North America Radiopharmaceuticals Market Analysis, by Bismuth 213, 2013-2022 ($MN)
Table 59 North America Radiopharmaceuticals Market Analysis, by Other Alpha Emitters, 2013-2022 ($MN)
Table 60 North America Radiopharmaceuticals Market Analysis, by Brachytherapy Isotopes, 2013-2022 ($MN)
Table 61 North America Radiopharmaceuticals Market Analysis, by Palladium 103, 2013-2022 ($MN)
Table 62 North America Radiopharmaceuticals Market Analysis, by Iodine 125, 2013-2022 ($MN)
Table 63 North America Radiopharmaceuticals Market Analysis, by Cesium 131, 2013-2022 ($MN)
Table 64 North America Radiopharmaceuticals Market Analysis, by Other Brachytherapy Isotopes, 2013-2022 ($MN)
Table 65 North America Radiopharmaceuticals Market Analysis, by PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 66 North America Radiopharmaceuticals Market Analysis, by Rubidium 82, 2013-2022 ($MN)
Table 67 North America Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 68 North America Radiopharmaceuticals Market Analysis, by Other PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 69 North America Radiopharmaceuticals Market Analysis, by SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 70 North America Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 71 North America Radiopharmaceuticals Market Analysis, by Iodine 123, 2013-2022 ($MN)
Table 72 North America Radiopharmaceuticals Market Analysis, by Technetium 99m, 2013-2022 ($MN)
Table 73 North America Radiopharmaceuticals Market Analysis, by Thallium 201, 2013-2022 ($MN)
Table 74 North America Radiopharmaceuticals Market Analysis, by Xenon 133, 2013-2022 ($MN)
Table 75 North America Radiopharmaceuticals Market Analysis, by Other SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 76 North America Radiopharmaceuticals Market Analysis, by Application, 2013-2022 ($MN)
Table 77 North America Radiopharmaceuticals Market Analysis, by Cardiology, 2013-2022 ($MN)
Table 78 North America Radiopharmaceuticals Market Analysis, by Bone Metastasis, 2013-2022 ($MN)
Table 79 North America Radiopharmaceuticals Market Analysis, by Endocrine Tumors, 2013-2022 ($MN)
Table 80 North America Radiopharmaceuticals Market Analysis, by Lymphoma, 2013-2022 ($MN)
Table 81 North America Radiopharmaceuticals Market Analysis, by Thyroid, 2013-2022 ($MN)
Table 82 North America Radiopharmaceuticals Market Analysis, by Neurology, 2013-2022 ($MN)
Table 83 North America Radiopharmaceuticals Market Analysis, by Oncology, 2013-2022 ($MN)
Table 84 North America Radiopharmaceuticals Market Analysis, by Gastroenterology, 2013-2022 ($MN)
Table 85 North America Radiopharmaceuticals Market Analysis, by Other Applications, 2013-2022 ($MN)
Table 86 North America Radiopharmaceuticals Market Analysis, by End User, 2013-2022 ($MN)
Table 87 North America Radiopharmaceuticals Market Analysis, by Diagnostic Imaging Centers, 2013-2022 ($MN)
Table 88 North America Radiopharmaceuticals Market Analysis, by Ambulatory Surgical Centers, 2013-2022 ($MN)
Table 89 North America Radiopharmaceuticals Market Analysis, by Cancer research Institutes, 2013-2022 ($MN)
Table 90 North America Radiopharmaceuticals Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 91 Europe Radiopharmaceuticals Market Analysis, by Country, 2013-2022 ($MN)
Table 92 Europe Radiopharmaceuticals Market Analysis, by Modality, 2013-2022 ($MN)
Table 93 Europe Radiopharmaceuticals Market Analysis, by Beta Emitters, 2013-2022 ($MN)
Table 94 Europe Radiopharmaceuticals Market Analysis, by Strontium 89, 2013-2022 ($MN)
Table 95 Europe Radiopharmaceuticals Market Analysis, by Yttrium 90, 2013-2022 ($MN)
Table 96 Europe Radiopharmaceuticals Market Analysis, by Samarium 153, 2013-2022 ($MN)
Table 97 Europe Radiopharmaceuticals Market Analysis, by Rhenium 186/188, 2013-2022 ($MN)
Table 98 Europe Radiopharmaceuticals Market Analysis, by Phosphorus 32, 2013-2022 ($MN)
Table 99 Europe Radiopharmaceuticals Market Analysis, by Iodine 131, 2013-2022 ($MN)
Table 100 Europe Radiopharmaceuticals Market Analysis, by Other Beta Emitters, 2013-2022 ($MN)
Table 101 Europe Radiopharmaceuticals Market Analysis, by Alpha Emitters, 2013-2022 ($MN)
Table 102 Europe Radiopharmaceuticals Market Analysis, by Radium 223, 2013-2022 ($MN)
Table 103 Europe Radiopharmaceuticals Market Analysis, by Bismuth 213, 2013-2022 ($MN)
Table 104 Europe Radiopharmaceuticals Market Analysis, by Other Alpha Emitters, 2013-2022 ($MN)
Table 105 Europe Radiopharmaceuticals Market Analysis, by Brachytherapy Isotopes, 2013-2022 ($MN)
Table 106 Europe Radiopharmaceuticals Market Analysis, by Palladium 103, 2013-2022 ($MN)
Table 107 Europe Radiopharmaceuticals Market Analysis, by Iodine 125, 2013-2022 ($MN)
Table 108 Europe Radiopharmaceuticals Market Analysis, by Cesium 131, 2013-2022 ($MN)
Table 109 Europe Radiopharmaceuticals Market Analysis, by Other Brachytherapy Isotopes, 2013-2022 ($MN)
Table 110 Europe Radiopharmaceuticals Market Analysis, by PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 111 Europe Radiopharmaceuticals Market Analysis, by Rubidium 82, 2013-2022 ($MN)
Table 112 Europe Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 113 Europe Radiopharmaceuticals Market Analysis, by Other PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 114 Europe Radiopharmaceuticals Market Analysis, by SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 115 Europe Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 116 Europe Radiopharmaceuticals Market Analysis, by Iodine 123, 2013-2022 ($MN)
Table 117 Europe Radiopharmaceuticals Market Analysis, by Technetium 99m, 2013-2022 ($MN)
Table 118 Europe Radiopharmaceuticals Market Analysis, by Thallium 201, 2013-2022 ($MN)
Table 119 Europe Radiopharmaceuticals Market Analysis, by Xenon 133, 2013-2022 ($MN)
Table 120 Europe Radiopharmaceuticals Market Analysis, by Other SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 121 Europe Radiopharmaceuticals Market Analysis, by Application, 2013-2022 ($MN)
Table 122 Europe Radiopharmaceuticals Market Analysis, by Cardiology, 2013-2022 ($MN)
Table 123 Europe Radiopharmaceuticals Market Analysis, by Bone Metastasis, 2013-2022 ($MN)
Table 124 Europe Radiopharmaceuticals Market Analysis, by Endocrine Tumors, 2013-2022 ($MN)
Table 125 Europe Radiopharmaceuticals Market Analysis, by Lymphoma, 2013-2022 ($MN)
Table 126 Europe Radiopharmaceuticals Market Analysis, by Thyroid, 2013-2022 ($MN)
Table 127 Europe Radiopharmaceuticals Market Analysis, by Neurology, 2013-2022 ($MN)
Table 128 Europe Radiopharmaceuticals Market Analysis, by Oncology, 2013-2022 ($MN)
Table 129 Europe Radiopharmaceuticals Market Analysis, by Gastroenterology, 2013-2022 ($MN)
Table 130 Europe Radiopharmaceuticals Market Analysis, by Other Applications, 2013-2022 ($MN)
Table 131 Europe Radiopharmaceuticals Market Analysis, by End User, 2013-2022 ($MN)
Table 132 Europe Radiopharmaceuticals Market Analysis, by Diagnostic Imaging Centers, 2013-2022 ($MN)
Table 133 Europe Radiopharmaceuticals Market Analysis, by Ambulatory Surgical Centers, 2013-2022 ($MN)
Table 134 Europe Radiopharmaceuticals Market Analysis, by Cancer research Institutes, 2013-2022 ($MN)
Table 135 Europe Radiopharmaceuticals Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 136 Asia Pacific Radiopharmaceuticals Market Analysis, by Country, 2013-2022 ($MN)
Table 137 Asia Pacific Radiopharmaceuticals Market Analysis, by Modality, 2013-2022 ($MN)
Table 138 Asia Pacific Radiopharmaceuticals Market Analysis, by Beta Emitters, 2013-2022 ($MN)
Table 139 Asia Pacific Radiopharmaceuticals Market Analysis, by Strontium 89, 2013-2022 ($MN)
Table 140 Asia Pacific Radiopharmaceuticals Market Analysis, by Yttrium 90, 2013-2022 ($MN)
Table 141 Asia Pacific Radiopharmaceuticals Market Analysis, by Samarium 153, 2013-2022 ($MN)
Table 142 Asia Pacific Radiopharmaceuticals Market Analysis, by Rhenium 186/188, 2013-2022 ($MN)
Table 143 Asia Pacific Radiopharmaceuticals Market Analysis, by Phosphorus 32, 2013-2022 ($MN)
Table 144 Asia Pacific Radiopharmaceuticals Market Analysis, by Iodine 131, 2013-2022 ($MN)
Table 145 Asia Pacific Radiopharmaceuticals Market Analysis, by Other Beta Emitters, 2013-2022 ($MN)
Table 146 Asia Pacific Radiopharmaceuticals Market Analysis, by Alpha Emitters, 2013-2022 ($MN)
Table 147 Asia Pacific Radiopharmaceuticals Market Analysis, by Radium 223, 2013-2022 ($MN)
Table 148 Asia Pacific Radiopharmaceuticals Market Analysis, by Bismuth 213, 2013-2022 ($MN)
Table 149 Asia Pacific Radiopharmaceuticals Market Analysis, by Other Alpha Emitters, 2013-2022 ($MN)
Table 150 Asia Pacific Radiopharmaceuticals Market Analysis, by Brachytherapy Isotopes, 2013-2022 ($MN)
Table 151 Asia Pacific Radiopharmaceuticals Market Analysis, by Palladium 103, 2013-2022 ($MN)
Table 152 Asia Pacific Radiopharmaceuticals Market Analysis, by Iodine 125, 2013-2022 ($MN)
Table 153 Asia Pacific Radiopharmaceuticals Market Analysis, by Cesium 131, 2013-2022 ($MN)
Table 154 Asia Pacific Radiopharmaceuticals Market Analysis, by Other Brachytherapy Isotopes, 2013-2022 ($MN)
Table 155 Asia Pacific Radiopharmaceuticals Market Analysis, by PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 156 Asia Pacific Radiopharmaceuticals Market Analysis, by Rubidium 82, 2013-2022 ($MN)
Table 157 Asia Pacific Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 158 Asia Pacific Radiopharmaceuticals Market Analysis, by Other PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 159 Asia Pacific Radiopharmaceuticals Market Analysis, by SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 160 Asia Pacific Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 161 Asia Pacific Radiopharmaceuticals Market Analysis, by Iodine 123, 2013-2022 ($MN)
Table 162 Asia Pacific Radiopharmaceuticals Market Analysis, by Technetium 99m, 2013-2022 ($MN)
Table 163 Asia Pacific Radiopharmaceuticals Market Analysis, by Thallium 201, 2013-2022 ($MN)
Table 164 Asia Pacific Radiopharmaceuticals Market Analysis, by Xenon 133, 2013-2022 ($MN)
Table 165 Asia Pacific Radiopharmaceuticals Market Analysis, by Other SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 166 Asia Pacific Radiopharmaceuticals Market Analysis, by Application, 2013-2022 ($MN)
Table 167 Asia Pacific Radiopharmaceuticals Market Analysis, by Cardiology, 2013-2022 ($MN)
Table 168 Asia Pacific Radiopharmaceuticals Market Analysis, by Bone Metastasis, 2013-2022 ($MN)
Table 169 Asia Pacific Radiopharmaceuticals Market Analysis, by Endocrine Tumors, 2013-2022 ($MN)
Table 170 Asia Pacific Radiopharmaceuticals Market Analysis, by Lymphoma, 2013-2022 ($MN)
Table 171 Asia Pacific Radiopharmaceuticals Market Analysis, by Thyroid, 2013-2022 ($MN)
Table 172 Asia Pacific Radiopharmaceuticals Market Analysis, by Neurology, 2013-2022 ($MN)
Table 173 Asia Pacific Radiopharmaceuticals Market Analysis, by Oncology, 2013-2022 ($MN)
Table 174 Asia Pacific Radiopharmaceuticals Market Analysis, by Gastroenterology, 2013-2022 ($MN)
Table 175 Asia Pacific Radiopharmaceuticals Market Analysis, by Other Applications, 2013-2022 ($MN)
Table 176 Asia Pacific Radiopharmaceuticals Market Analysis, by End User, 2013-2022 ($MN)
Table 177 Asia Pacific Radiopharmaceuticals Market Analysis, by Diagnostic Imaging Centers, 2013-2022 ($MN)
Table 178 Asia Pacific Radiopharmaceuticals Market Analysis, by Ambulatory Surgical Centers, 2013-2022 ($MN)
Table 179 Asia Pacific Radiopharmaceuticals Market Analysis, by Cancer research Institutes, 2013-2022 ($MN)
Table 180 Asia Pacific Radiopharmaceuticals Market Analysis, by Hospitals, 2013-2022 ($MN)
Table 181 RoW Radiopharmaceuticals Market Analysis, by Country, 2013-2022 ($MN)
Table 182 RoW Radiopharmaceuticals Market Analysis, by Modality, 2013-2022 ($MN)
Table 183 RoW Radiopharmaceuticals Market Analysis, by Beta Emitters, 2013-2022 ($MN)
Table 184 RoW Radiopharmaceuticals Market Analysis, by Strontium 89, 2013-2022 ($MN)
Table 185 RoW Radiopharmaceuticals Market Analysis, by Yttrium 90, 2013-2022 ($MN)
Table 186 RoW Radiopharmaceuticals Market Analysis, by Samarium 153, 2013-2022 ($MN)
Table 187 RoW Radiopharmaceuticals Market Analysis, by Rhenium 186/188, 2013-2022 ($MN)
Table 188 RoW Radiopharmaceuticals Market Analysis, by Phosphorus 32, 2013-2022 ($MN)
Table 189 RoW Radiopharmaceuticals Market Analysis, by Iodine 131, 2013-2022 ($MN)
Table 190 RoW Radiopharmaceuticals Market Analysis, by Other Beta Emitters, 2013-2022 ($MN)
Table 191 RoW Radiopharmaceuticals Market Analysis, by Alpha Emitters, 2013-2022 ($MN)
Table 192 RoW Radiopharmaceuticals Market Analysis, by Radium 223, 2013-2022 ($MN)
Table 193 RoW Radiopharmaceuticals Market Analysis, by Bismuth 213, 2013-2022 ($MN)
Table 194 RoW Radiopharmaceuticals Market Analysis, by Other Alpha Emitters, 2013-2022 ($MN)
Table 195 RoW Radiopharmaceuticals Market Analysis, by Brachytherapy Isotopes, 2013-2022 ($MN)
Table 196 RoW Radiopharmaceuticals Market Analysis, by Palladium 103, 2013-2022 ($MN)
Table 197 RoW Radiopharmaceuticals Market Analysis, by Iodine 125, 2013-2022 ($MN)
Table 198 RoW Radiopharmaceuticals Market Analysis, by Cesium 131, 2013-2022 ($MN)
Table 199 RoW Radiopharmaceuticals Market Analysis, by Other Brachytherapy Isotopes, 2013-2022 ($MN)
Table 200 RoW Radiopharmaceuticals Market Analysis, by PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 201 RoW Radiopharmaceuticals Market Analysis, by Rubidium 82, 2013-2022 ($MN)
Table 202 RoW Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 203 RoW Radiopharmaceuticals Market Analysis, by Other PET Radiopharmaceuticals, 2013-2022 ($MN)
Table 204 RoW Radiopharmaceuticals Market Analysis, by SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 205 RoW Radiopharmaceuticals Market Analysis, by Fluorine 18, 2013-2022 ($MN)
Table 206 RoW Radiopharmaceuticals Market Analysis, by Iodine 123, 2013-2022 ($MN)
Table 207 RoW Radiopharmaceuticals Market Analysis, by Technetium 99m, 2013-2022 ($MN)
Table 208 RoW Radiopharmaceuticals Market Analysis, by Thallium 201, 2013-2022 ($MN)
Table 209 RoW Radiopharmaceuticals Market Analysis, by Xenon 133, 2013-2022 ($MN)
Table 210 RoW Radiopharmaceuticals Market Analysis, by Other SPECT Radiopharmaceuticals, 2013-2022 ($MN)
Table 211 RoW Radiopharmaceuticals Market Analysis, by Application, 2013-2022 ($MN)
Table 212 RoW Radiopharmaceuticals Market Analysis, by Cardiology, 2013-2022 ($MN)
Table 213 RoW Radiopharmaceuticals Market Analysis, by Bone Metastasis, 2013-2022 ($MN)
Table 214 RoW Radiopharmaceuticals Market Analysis, by Endocrine Tumors, 2013-2022 ($MN)
Table 215 RoW Radiopharmaceuticals Market Analysis, by Lymphoma, 2013-2022 ($MN)
Table 216 RoW Radiopharmaceuticals Market Analysis, by Thyroid, 2013-2022 ($MN)
Table 217 RoW Radiopharmaceuticals Market Analysis, by Neurology, 2013-2022 ($MN)
Table 218 RoW Radiopharmaceuticals Market Analysis, by Oncology, 2013-2022 ($MN)
Table 219 RoW Radiopharmaceuticals Market Analysis, by Gastroenterology, 2013-2022 ($MN)
Table 220 RoW Radiopharmaceuticals Market Analysis, by Other Applications, 2013-2022 ($MN)
Table 221 RoW Radiopharmaceuticals Market Analysis, by End User, 2013-2022 ($MN)
Table 222 RoW Radiopharmaceuticals Market Analysis, by Diagnostic Imaging Centers, 2013-2022 ($MN)
Table 223 RoW Radiopharmaceuticals Market Analysis, by Ambulatory Surgical Centers, 2013-2022 ($MN)
Table 224 RoW Radiopharmaceuticals Market Analysis, by Cancer research Institutes, 2013-2022 ($MN)
Table 225 RoW Radiopharmaceuticals Market Analysis, by Hospitals, 2013-2022 ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Advanced Accelerator Applications
  • Advanced Medical Isotope Corp
  • Bayer AG
  • Bracco Imaging SpA
  • Covidien Plc
  • Daiichi Sankyo Co., Ltd.
  • Eckert & Ziegler
  • Eczacibasi-Monrol Nuclear Products
  • Fujifilm RI Pharma Co. Ltd
  • GE Healthcare (General Electric Co.)
  • Guerbet Group
  • IBA Molecular Imaging
  • Lantheus Medical Imaging, Inc
  • Mallinckrodt plc
  • Nordion, Inc.
  • NTP Radioisotopes Pty Ltd
  • Positron Corporation
  • Siemens Healthineers (Siemens AG)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll